Human GRO gamma/CXCL3 enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 0.73 pg/ml (50 μl);0.95pg/ml (10 μl); |
| Standard Curve Range | 1.37~1000 pg/ml |
| Standard Curve Gradient | 7 Points/3 Folds |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 50 μl/10 μl |
| Type | Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0.00 | 0.0350 | 0.0298 | 0.0324 | |
| 1.37 | 0.0464 | 0.0444 | 0.0454 | 0.0130 |
| 4.12 | 0.0787 | 0.0773 | 0.0780 | 0.0456 |
| 12.35 | 0.1843 | 0.1818 | 0.1831 | 0.1507 |
| 37.04 | 0.4723 | 0.4890 | 0.4807 | 0.4483 |
| 111.11 | 1.2810 | 1.3080 | 1.2945 | 1.2621 |
| 333.33 | 2.9920 | 2.9530 | 2.9725 | 2.9401 |
| 1000.00 | 4.5153 | 4.6283 | 4.5718 | 4.5394 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 14.0 | 86.3 | 297.4 | 28.4 | 168.4 | 534.4 |
| Standard Deviation | 0.7 | 4.6 | 22.2 | 1.3 | 5.7 | 37.3 |
| Coefficient of Variation(%) | 4.7 | 5.3 | 7.5 | 3.9 | 2.1 | 3.3 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human GRO gamma/CXCL3 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 89% to 118% with an overall mean recovery of 101%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | 202.10-1297.02 | 100 | 417.08 |
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human GRO gamma/CXCL3 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: GRO gamma/CXCL3
CINC-2 alpha and -2 beta are mRNA splice variant isoforms that differ by only 3 amino acids at their amino-termini. These proteins are CXC chemokines most closely related to human GROs and mouse MIP-2. They are produced by granulation tissue, activated macrophages and fibroblasts. CINC-2 biological activities are mediated by CXCR1 or CXCR2.
